Cannabidiol, ∆

CBD metabolites UHPLC-MS/MS cannabinoids medical cannabis serum

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2022
Historique:
received: 07 09 2022
accepted: 10 10 2022
entrez: 10 11 2022
pubmed: 11 11 2022
medline: 11 11 2022
Statut: epublish

Résumé

Cannabidiol (CBD) exhibits anti-inflammatory, anxiolytic, antiseizure, and neuroprotective proprieties without addictive or psychotropic side effects, as opposed to Δ

Identifiants

pubmed: 36353497
doi: 10.3389/fphar.2022.1038754
pii: 1038754
pmc: PMC9637868
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1038754

Informations de copyright

Copyright © 2022 Pigliasco, Malaca, Lo Faro, Tini, Cangemi, Cafaro, Barco, Riva, Pisati, Amadori, Striano, Tagliabracci, Huestis and Busardò.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Bioanalysis. 2018 Dec;10(24):2003-2014
pubmed: 30412688
Drugs Today (Barc). 2019 Mar;55(3):177-196
pubmed: 30938373
Pharmaceuticals (Basel). 2021 Jan 13;14(1):
pubmed: 33451073
Med Sci Monit. 2008 Oct;14(10):RA173-8
pubmed: 18830207
Ther Drug Monit. 2019 Oct;41(5):681-692
pubmed: 31095069
Pharmaceuticals (Basel). 2020 Dec 12;13(12):
pubmed: 33322849
Curr Pharm Des. 2017;23(36):5442-5454
pubmed: 28714407
Ther Drug Monit. 2018 Oct;40(5):526-548
pubmed: 29957667
Phytother Res. 2021 Mar;35(3):1646-1657
pubmed: 33155722
CNS Drugs. 2020 Mar;34(3):229-241
pubmed: 32040850
Front Pharmacol. 2020 Nov 16;11:582286
pubmed: 33364956
Molecules. 2020 Aug 08;25(16):
pubmed: 32784413
Ther Drug Monit. 2019 Apr;41(2):168-173
pubmed: 30883510
Talanta. 2020 Mar 1;209:120537
pubmed: 31892011
Talanta. 2020 Jan 1;206:120236
pubmed: 31514837
J Pharm Biomed Anal. 2017 Oct 25;145:704-710
pubmed: 28806566
Cannabis Cannabinoid Res. 2016 Mar 01;1(1):90-101
pubmed: 28861484
Curr Pharm Des. 2017;23(36):5455-5467
pubmed: 28641530
Anal Bioanal Chem. 2013 May;405(14):4679-89
pubmed: 23494274
Pharmaceuticals (Basel). 2021 Jun 29;14(7):
pubmed: 34209666
Epileptic Disord. 2020 Feb 1;22(1):1-14
pubmed: 32096470
Talanta. 2021 Feb 1;223(Pt 2):121772
pubmed: 33298281

Auteurs

Federica Pigliasco (F)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.

Sara Malaca (S)

Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona, Italy.

Alfredo Fabrizio Lo Faro (AF)

Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona, Italy.

Anastasio Tini (A)

Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona, Italy.

Giuliana Cangemi (G)

Chromatography and Mass Spectrometry Section, Central Laboratory of Analyses, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Alessia Cafaro (A)

Chromatography and Mass Spectrometry Section, Central Laboratory of Analyses, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Department of Internal Medicine, Pharmacology & Toxicology Unit, University of Genoa, Genoa, Italy.

Sebastiano Barco (S)

Chromatography and Mass Spectrometry Section, Central Laboratory of Analyses, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Antonella Riva (A)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.

Angelica Pisati (A)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.

Elisabetta Amadori (E)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.

Pasquale Striano (P)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Paediatric Neurology and Muscular Disease Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Adriano Tagliabracci (A)

Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona, Italy.

Marilyn Ann Huestis (MA)

Institute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, PA, United States.

Francesco Paolo Busardò (FP)

Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona, Italy.

Classifications MeSH